Related Experiment Video
Updated: May 13, 2026
A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
Published on: May 31, 2024
The pediatric pouch in inflammatory bowel disease: a primer for the gastroenterologist
Ghassan T Wahbeh1, David L Suskind, Scott D Lee
1Inflammatory Bowel Disease Program, Seattle Children's Hospital, University of Washington, W7830, Gastroenterology, 4800 Sand Point Way NE, Seattle, WA 98105, USA. ghassan.wahbeh@seattlechildrens.org
Insights
Surgery, including colectomy and ileal pouch-anal anastomosis, effectively treats severe pediatric ulcerative colitis unresponsive to medication. Most children and families report satisfaction with pouch surgery outcomes despite potential complications.
Area of Science:
- Pediatric Gastroenterology
- Surgical Gastroenterology
- Inflammatory Bowel Disease Research
Background:
- Severe pediatric ulcerative colitis (UC) often requires advanced treatment strategies when medical therapies fail.
- Surgical intervention, specifically colectomy with ileal pouch-anal anastomosis (IPAA), is a viable option for refractory cases.
- Understanding the implications and potential complications of IPAA is crucial for informed decision-making in pediatric UC management.
Purpose of the Study:
- To evaluate the efficacy and outcomes of surgical management, specifically IPAA, for pediatric patients with severe ulcerative colitis.
- To identify and discuss critical considerations, potential complications, and long-term risks associated with IPAA in children.
- To assess patient and family satisfaction levels following IPAA for refractory pediatric ulcerative colitis.
Main Methods:
- Review of surgical management strategies for pediatric ulcerative colitis resistant to medical treatment.
- Discussion of key factors influencing the decision-making process for IPAA, including alternative procedures and expected outcomes.
- Analysis of potential surgical complications (e.g., leak, sepsis, strictures, inflammation) and long-term risks (e.g., Crohn's disease, malignancy, fertility).
Main Results:
- IPAA is a successful surgical option for pediatric patients with severe ulcerative colitis unresponsive to medical therapy.
- Despite risks such as surgical leak, pelvic sepsis, anastomotic strictures, and pouch inflammation, most patients achieve satisfactory outcomes.
- The decision for IPAA involves significant emotional considerations for children and their families, alongside a long-term risk of malignancy in residual colonic tissue.
Conclusions:
- Surgical management with IPAA offers a successful treatment pathway for severe pediatric ulcerative colitis.
- Comprehensive discussion of risks, benefits, and expectations is essential before offering IPAA.
- Further research is needed to identify preoperative risk predictors and optimize the prevention and treatment of IPAA-related complications.
Abstract:
Pediatric severe ulcerative colitis that is resistant to current medical treatment can successfully be managed surgically with a colectomy, ileal pouch creation and pouch-anal anastomosis. Key issues that should be considered and discussed before the pouch option can be offered include alternative surgical procedures, pouch function expectations, risk of surgical leak, pelvic sepsis, anastomotic strictures, acute and chronic pouch inflammation, Crohn's disease of the pouch and risk of reduced fertility for females. A long-term risk is malignancy of the residual colonic tissue. The decision to proceed with a pouch or not poses a substantial emotional burden to the child and family. Despite the risk of surgical complications and pouch inflammatory and functional challenges, the overwhelming majority of children and their families are satisfied with their pouch surgery outcomes. Further study is needed to assess preoperative risk predictors, prevention and treatment of complications.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:26Inflammatory Bowel Disease I: Introduction
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...